These results suggested that HSPB8, FADD, ITGA3, and CDKN2A are repeatable targets in HNSCC, which may also play a role in OSCC, and FADD and NKX2-3 may have high prognostic and therapeutic value in OSCC. This evidence concerns the gene FADD and head and neck squamous cell carcinoma.